Latest return on equity
Novo Nordisk Return on equity
Direct answer
Novo Nordisk's return on equity is 59.81%.
The verified market snapshot reports 59.81%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 9, 2026.
Get free Novo Nordisk email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- 59.81%
Explore related company data
View Novo Nordisk's market capitalizationView Novo Nordisk's p/e ratioView Novo Nordisk's price-to-book ratioView Novo Nordisk's dividend yieldView Novo Nordisk's 52-week price rangeView Novo Nordisk's revenue growthView Novo Nordisk's profit marginView Novo Nordisk's debt-to-equity ratioView all Novo Nordisk key metricsReturn to Novo Nordisk profile